| Date Filed | Type | Description |
| 10/04/2023 |
8-K
| Investor presentation |
| 10/03/2023 |
4
| CODE KENNETH REAY (Chief Science Officer) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 19,010 shares
@ $0.1657, valued at
$3.1k
|
|
| 10/03/2023 |
4
| STROMMEN JACK B. (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 90,525 options to buy
@ $0.1657, valued at
$15k
|
|
| 10/03/2023 |
4
| Bray Christina Elaine (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 113,156 options to buy
@ $0.1657, valued at
$18.7k
|
|
| 10/03/2023 |
4
| Park Linda (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 113,156 options to buy
@ $0.1657, valued at
$18.7k
|
|
| 10/03/2023 |
4
| Marshall Dennis E (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 113,156 options to buy
@ $0.1657, valued at
$18.7k
|
|
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| DARGAN CHARLES K (CFO) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.18, valued at
$90k
|
|
| 07/05/2023 |
4
| CODE KENNETH REAY (Chief Science Officer) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 68,541 shares
@ $0.178, valued at
$12.2k
|
|
| 07/05/2023 |
4
| STROMMEN JACK B. (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 84,270 options to buy
@ $0.178, valued at
$15k
|
|
| 07/05/2023 |
4
| Marshall Dennis E (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 105,337 options to buy
@ $0.178, valued at
$18.7k
|
|
| 07/05/2023 |
4
| Park Linda (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 105,337 options to buy
@ $0.178, valued at
$18.7k
|
|
| 07/05/2023 |
4
| Bray Christina Elaine (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 105,337 options to buy
@ $0.178, valued at
$18.7k
|
|
| 06/12/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 06/09/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 06/06/2023 |
8-K
| Investor presentation |
| 05/23/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 05/18/2023 |
8-K
| Investor presentation |
| 05/17/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/16/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/11/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/09/2023 |
POS EX
| Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]: |
| 05/09/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 04/27/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 04/24/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 04/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/20/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/14/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
4
| Bray Christina Elaine (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 91,508 options to buy
@ $0.2049, valued at
$18.7k
|
|
| 04/04/2023 |
4
| Park Linda (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 91,508 options to buy
@ $0.2049, valued at
$18.7k
|
|
| 04/04/2023 |
4
| Marshall Dennis E (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 91,508 options to buy
@ $0.2049, valued at
$18.7k
|
|
| 04/04/2023 |
4
| CODE KENNETH REAY (Chief Science Officer) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 30,747 shares
@ $0.2049, valued at
$6.3k
|
|
| 04/04/2023 |
4
| STROMMEN JACK B. (Director) has filed a Form 4 on BIOLARGO, INC.|
Txns:
| Granted 73,206 options to buy
@ $0.2049, valued at
$15k
|
|
|